This grifol family entrusts the management of the pharmaceutical company to Thomas Glanzmann, who has been appointed as the new CEO of the company, as reported in a notice sent by the group to CNMV. Víctor Grifols Deu is the Chief Operating Officer, and Ramón Grifols is the Corporate General Manager. With this move, the management of the company falls into the hands of an outside person; This was a step taken by the Grifols family when an external person, Steven F. Mayer, was appointed chairman in September 2022.
Thus, Víctor Grifols will focus on the day-to-day management of the company from his position as Chief Operating Officer. All operational functions will be subordinate to him and he will continue to be a member of the board of directors. In addition to his duties on the board, Raimon Grifols, the company’s current vice president, said: optimizing the value of affiliates and corporate associations He leads major corporate initiatives alongside Grifols”, from his new position as corporate CEO.
The company explains that these changes are aimed at accelerating the implementation of its strategic plan and are part of the context of restructuring initiated by the creation of business units by Grifols. In February 2023, Grifols operational improvement plan promoting measures to increase their competitiveness, reduce their cost base and improve their efficiency and organizational effectiveness.
Restructuring of decision making
The company then created the chief executive figure to centralize its most strategic decision-making. He founded SELT (Senior Executive Leadership Team) two months ago and now functional changes in your dome directive.
“I am confident these changes will position us for the next phase of growth and will help us achieve results and accelerate our performance to abide by our commitments to all our stakeholders,” stressed Glanzmann, Chairman and CEO of Grifols.
Glanzmann will be responsible for Grifols’ business decisions as he and his management team formulate and implement the company’s short- and long-term strategies.